Chloe Duffield
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chloe Duffield has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Yuling Wang
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, Australia
3 shared publications - Laura Marcela Rey Gomez
School of Natural Sciences Faculty of Science and Engineering Macquarie University Sydney New South Wales Australia
2 shared publications Simon Chang-Hao Tsao
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Australia
2 shared publications- David William Inglis
School of Engineering Macquarie University Sydney New South Wales Australia
1 shared publication Nana Lyu
Department of Molecular Sciences, ARC Centre of Excellence for Nanoscale BioPhotonics, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, Australia
1 shared publication- Su Su Thae Hnit
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Australia
1 shared publication
Latest Publications
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (49) , 8915-8918
Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles
Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.
- 21 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (49) , 8915-8918
Multi-line lateral flow immunoassay for the detection and subtyping of breast cancer-derived small extracellular vesicles
Cancer cell-derived small extracellular vesicles (sEVs) are new promising biomarkers for improved cancer diagnosis. A multi-line lateral flow immunoassay (LFIA) has been proposed for sensitive detection and subtyping of breast cancer-derived sEVs. The expression of cancer surface biomarkers (EpCAM) was confirmed through colorimetric analysis of cell line-derived sEVs (p = 0.076) and patient samples, highlighting the potential for their use as a clinical aid.
- 7 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (7) , 3635-3655
Recent advances in SERS assays for detection of multiple extracellular vesicles biomarkers for cancer diagnosis
This review provides insights on recent advances using label-free and label-based SERS assays for detecting multiple small extracellular vesicle biomarkers for cancer diagnosis, including issues surrounding their translation from lab to clinic.
- 7 December 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (7) , 3635-3655
Recent advances in SERS assays for detection of multiple extracellular vesicles biomarkers for cancer diagnosis
This review provides insights on recent advances using label-free and label-based SERS assays for detecting multiple small extracellular vesicle biomarkers for cancer diagnosis, including issues surrounding their translation from lab to clinic.
- Open Access
- 27 July 2021
- Published by World Scientific Pub Co Pte Ltd in Journal of Innovative Optical Health Sciences
- Vol. 14 (04)
Synthesis and characterization of reporter molecules embedded core-shell nanoparticles as SERS nanotags
Surface-enhanced Raman scattering (SERS) spectroscopy is presented as a sensitive and specific molecular tool for clinical diagnosis and prognosis monitoring of various diseases including cancer. In order for clinical application of SERS technique, an ideal method of bulk synthesis of SERS nanoparticles is necessary to obtain sensitive, stable and highly reproducible Raman signals. In this contribution, we determined the ideal conditions for bulk synthesis of Raman reporter (Ra) molecules embedded silver-gold core-shell nanoparticles (Au@Ra@ AgNPs) using hydroquinone as reducing agent of silver nitrate. By using UV-Vis spectroscopy, Raman spectroscopy and transmission electron microscopy (TEM), we found that a 2:1 ratio of silver nitrate to hydroquinone is ideal for a uniform silver coating with a strong and stable Raman signal. Through stability testing of the optimized Au@Ra@AgNPs over a two-week period, these SERS nanotags were found to be stable with minimal signal change occurred. The stability of antibody linked SERS nanotags is also crucial for cancer and disease diagnosis, thus, we further conjugated the as-prepared SERS nanotags with anti-EpCAM antibody, in which the stability of bioconjugated SERS nanotags was tested over eight days. Both UV-Vis and SERS spectroscopy showed stable absorption and Raman signals on the anti-EpCAM conjugated SERS nanotags, indicating the great potential of the synthesized SERS nanotags for future applications which require large, reproducible and uniform quantities in order for cancer biomarker diagnosis and monitoring.
- 27 July 2021
- Published by World Scientific Pub Co Pte Ltd in Journal of Innovative Optical Health Sciences
- Vol. 14 (04)
Open AccessSynthesis and characterization of reporter molecules embedded core-shell nanoparticles as SERS nanotags
Surface-enhanced Raman scattering (SERS) spectroscopy is presented as a sensitive and specific molecular tool for clinical diagnosis and prognosis monitoring of various diseases including cancer. In order for clinical application of SERS technique, an ideal method of bulk synthesis of SERS nanoparticles is necessary to obtain sensitive, stable and highly reproducible Raman signals. In this contribution, we determined the ideal conditions for bulk synthesis of Raman reporter (Ra) molecules embedded silver-gold core-shell nanoparticles (Au@Ra@ AgNPs) using hydroquinone as reducing agent of silver nitrate. By using UV-Vis spectroscopy, Raman spectroscopy and transmission electron microscopy (TEM), we found that a 2:1 ratio of silver nitrate to hydroquinone is ideal for a uniform silver coating with a strong and stable Raman signal. Through stability testing of the optimized Au@Ra@AgNPs over a two-week period, these SERS nanotags were found to be stable with minimal signal change occurred. The stability of antibody linked SERS nanotags is also crucial for cancer and disease diagnosis, thus, we further conjugated the as-prepared SERS nanotags with anti-EpCAM antibody, in which the stability of bioconjugated SERS nanotags was tested over eight days. Both UV-Vis and SERS spectroscopy showed stable absorption and Raman signals on the anti-EpCAM conjugated SERS nanotags, indicating the great potential of the synthesized SERS nanotags for future applications which require large, reproducible and uniform quantities in order for cancer biomarker diagnosis and monitoring.